Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
BAPS
MCID: BRT001
MIFTS: 49

Bart-Pumphrey Syndrome (BAPS)

Categories: Ear diseases, Fetal diseases, Genetic diseases, Rare diseases, Skin diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Bart-Pumphrey Syndrome

About this section

MalaCards integrated aliases for Bart-Pumphrey Syndrome:

Name: Bart-Pumphrey Syndrome 57 12 20 43 58 73 36 13 15
Knuckle Pads, Leukonychia, and Sensorineural Deafness 57 12 43 73
Knuckle Pads, Deafness and Leukonychia Syndrome 29 6 39
Knuckle Pads-Leukonychia-Sensorineural Deafness-Palmoplantar Hyperkeratosis Syndrome 20 58
Knuckle Pads-Leukonychia-Sensorineural Deafness-Palmoplantar Keratoderma Syndrome 20 58
Baps 57 73
Knuckle Pads-Leukonychia-Sensorineural Hearing Loss-Palmoplantar Hyperkeratosis Syndrome 58
Knuckle Pads-Leukonychia-Sensorineural Hearing Loss-Palmoplantar Keratoderma Syndrome 58
Knuckle Pads, Leuconychia and Sensorineural Deafness 20
Knuckle Pads, Deafness, and Leukonychia Syndrome 43

Characteristics:

Orphanet epidemiological data:

58
knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome
Prevalence: <1/1000000 (Worldwide); Age of onset: Childhood; Age of death: normal life expectancy;

OMIM®:

57 (Updated 05-Mar-2021)
Inheritance:
autosomal dominant


HPO:

31
bart-pumphrey syndrome:
Inheritance autosomal dominant inheritance


Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases Fetal diseases
Anatomical: Ear diseases Skin diseases
See all MalaCards categories (disease lists)
ICD10: 33
Orphanet: 58  
Rare otorhinolaryngological diseases
Rare skin diseases
Developmental anomalies during embryogenesis


External Ids:

Disease Ontology 12 DOID:0050658
OMIM® 57 149200
KEGG 36 H00706
ICD10 via Orphanet 33 Q82.8
UMLS via Orphanet 72 C0266004
Orphanet 58 ORPHA2698
MedGen 41 C0266004
Sources

Summaries for Bart-Pumphrey Syndrome

About this section
MedlinePlus Genetics : 43 Bart-Pumphrey syndrome is characterized by nail and skin abnormalities and hearing loss.People with Bart-Pumphrey syndrome typically have a white discoloration of the nails (leukonychia); the nails may also be thick and crumbly. Affected individuals often have wart-like (verrucous) skin growths called knuckle pads on the knuckles of the fingers and toes. They may also have thickening of the skin on the palms of the hands and soles of the feet (palmoplantar keratoderma). The skin abnormalities generally become noticeable during childhood.The hearing loss associated with Bart-Pumphrey syndrome ranges from moderate to profound and is typically present from birth (congenital).The signs and symptoms of this disorder may vary even within the same family; while almost all affected individuals have hearing loss, they may have different combinations of the other associated features.

MalaCards based summary : Bart-Pumphrey Syndrome, also known as knuckle pads, leukonychia, and sensorineural deafness, is related to keratoderma, palmoplantar, with deafness and keratosis. An important gene associated with Bart-Pumphrey Syndrome is GJB2 (Gap Junction Protein Beta 2), and among its related pathways/superpathways are Vesicle-mediated transport and G-Beta Gamma Signaling. The drugs Olaparib and Bevacizumab have been mentioned in the context of this disorder. Affiliated tissues include skin, and related phenotypes are sensorineural hearing impairment and subcutaneous nodule

Disease Ontology : 12 A syndrome that is characterized by leukonychia, wart-like skin growths, palmoplantar keratoderma and hearing loss, has material basis in heterozygous mutation in the GJB2 gene on chromosome 13q12.

GARD : 20 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 2698DefinitionA rare, syndromic genetic deafness disease characterized by symmetric or asymmetirc knuckle pads (typically located on the distal and interphalangeal joints), leukonychia, diffuse palmoplantar keratoderma, and congenital, mild to moderate sensorineural deafness.Visit the Orphanet disease page for more resources.

OMIM® : 57 Bart-Pumphrey syndrome (BAPS) is an autosomal dominant disorder characterized by sensorineural hearing loss, palmoplantar keratoderma, knuckle pads, and leukonychia, which show considerable phenotypic variability (summary by Richard et al., 2004). (149200) (Updated 05-Mar-2021)

KEGG : 36 Bart-Pumphrey syndrome is an autosomal dominant disorder characterized by congenital deafness and palmoplantar hyperkeratosis. Patients also display knuckle pads and leukonychia. GJB2, the gene encoding connexin-26, is mutated in the disease.

UniProtKB/Swiss-Prot : 73 Bart-Pumphrey syndrome: An autosomal dominant disorder characterized by sensorineural hearing loss, palmoplantar keratoderma, knuckle pads, and leukonychia, It shows considerable phenotypic variability.

Wikipedia : 74 Bart-Pumphrey syndrome (also known as "Palmoplantar keratoderma with knuckle pads and leukonychia and... more...

Sources

Related Diseases for Bart-Pumphrey Syndrome

About this section

Diseases related to Bart-Pumphrey Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 84)
# Related Disease Score Top Affiliating Genes
1 keratoderma, palmoplantar, with deafness 31.4 GJB6 GJB4 GJB3 GJB2 GJA1
2 keratosis 30.5 GJB3 GJB2 GJA1
3 ichthyosis 30.3 GJB6 GJB2 GJA1
4 palmoplantar keratosis 30.2 GJB4 GJB3 GJB2 GJA1
5 knuckle pads 30.1 GJB6 GJB4 GJB3 GJB2 GJA1
6 sensorineural hearing loss 29.5 MT-RNR1 GJB6 GJB3 GJB2 GJB1
7 vohwinkel syndrome 29.4 GJB6 GJB5 GJB4 GJB3 GJB2 GJA1
8 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.4
9 ainhum 10.3 GJB4 GJB2
10 nonsyndromic hearing loss and deafness, dfna3 10.2 GJB6 GJB2
11 purulent labyrinthitis 10.2 GJB6 GJB2
12 labyrinthitis 10.2 GJB6 GJB2
13 viral labyrinthitis 10.2 GJB6 GJB2
14 dupuytren contracture 10.2
15 keratitis, hereditary 10.2
16 branchiootic syndrome 1 10.2
17 deafness, autosomal dominant 2b 10.2 GJB3 GJB2
18 deafness, autosomal recessive 91 10.2 GJB3 GJB2
19 deafness, autosomal dominant 2a 10.2 GJB3 GJB2
20 deafness, autosomal dominant 9 10.1 GJB3 GJB2
21 x-linked charcot-marie-tooth disease 10.1 GJB2 GJB1
22 deafness, autosomal recessive 26 10.1 MT-RNR1 GJB2
23 mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma 10.1 GJB4 GJB3
24 hypotrichosis-deafness syndrome 10.1 GJB4 GJB3 GJB2
25 nonsyndromic hearing loss and deafness, dfnb1 10.1 GJB6 GJB3 GJB2
26 dfnb1 10.1 GJB6 GJB3 GJB2
27 deafness, autosomal dominant 3b 10.0 GJB6 GJB3 GJB2
28 inflammatory bowel disease 10.0
29 deafness, autosomal recessive 1b 10.0 GJB6 GJB3 GJB2
30 nevus, epidermal 10.0 GJB4 GJB3 GJB2
31 deafness, x-linked 2 10.0 GJB6 GJB3 GJB2
32 pelizaeus-merzbacher-like disease 10.0 GJB1 GJA1
33 deafness, aminoglycoside-induced 10.0 MT-RNR1 GJB2
34 keratitis-ichthyosis-deafness syndrome, autosomal dominant 10.0 GJB6 GJB2 GJA1
35 congenital cytomegalovirus 10.0 MT-RNR1 GJB6 GJB2
36 myasthenic syndrome, congenital, 12 10.0 MT-RNR1 GJA1
37 drug-induced hearing loss 9.9 MT-RNR1 GJB3 GJB2
38 deafness, autosomal recessive 12 9.9 GJB3 GJB2
39 pendred syndrome 9.9 MT-RNR1 GJB6 GJB2
40 syndactyly, type iii 9.9 GJC1 GJA1
41 balo concentric sclerosis 9.9 GJC3 GJB6
42 waardenburg's syndrome 9.9 MT-RNR1 GJB6 GJB2
43 deafness, autosomal dominant 3a 9.9 GJB6 GJB4 GJB3 GJB2
44 diaphragmatic hernia, congenital 9.9
45 crohn's colitis 9.9
46 bladder exstrophy 9.9
47 esophageal atresia 9.9
48 hydronephrosis 9.9
49 cholestasis 9.9
50 ulcerative colitis 9.9

Graphical network of the top 20 diseases related to Bart-Pumphrey Syndrome:



Diseases related to Bart-Pumphrey Syndrome
Sources

Symptoms & Phenotypes for Bart-Pumphrey Syndrome

About this section

Human phenotypes related to Bart-Pumphrey Syndrome:

58 31 (show all 6)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 sensorineural hearing impairment 58 31 hallmark (90%) Very frequent (99-80%) HP:0000407
2 subcutaneous nodule 58 31 hallmark (90%) Very frequent (99-80%) HP:0001482
3 leukonychia 58 31 hallmark (90%) Very frequent (99-80%) HP:0001820
4 palmoplantar keratoderma 58 31 frequent (33%) Frequent (79-30%) HP:0000982
5 hearing impairment 31 HP:0000365
6 hyperkeratosis 58 Very frequent (99-80%)

Symptoms via clinical synopsis from OMIM®:

57 (Updated 05-Mar-2021)
Nails:
leukonychia

Ears:
cochlear deafness

Limbs:
knuckle pads

Skin:
keratosis palmaris et plantaris

Clinical features from OMIM®:

149200 (Updated 05-Mar-2021)

MGI Mouse Phenotypes related to Bart-Pumphrey Syndrome:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.86 GJA1 GJB1 GJB2 GJB3 GJB4 GJB5
2 hearing/vestibular/ear MP:0005377 9.55 GJA1 GJB2 GJB3 GJB6 GJC3
3 immune system MP:0005387 9.5 GJA1 GJB1 GJB2 GJB3 GJB4 GJB6
4 no phenotypic analysis MP:0003012 9.02 GJA1 GJB2 GJB3 GJB6 GJC1
Sources

Drugs & Therapeutics for Bart-Pumphrey Syndrome

About this section

Drugs for Bart-Pumphrey Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Olaparib Approved Phase 2 763113-22-0 23725625
2
Bevacizumab Approved, Investigational Phase 2 216974-75-3
3
Silicon Approved, Investigational Phase 2 7440-21-3 4082203
4
Titanium dioxide Approved Phase 2 13463-67-7
5
Iron Approved Phase 2 7439-89-6 23925 29936
6
Mannitol Approved, Investigational Phase 2 69-65-8 453 6251
7 Ferrosoferric Oxide Phase 2
8 Poly(ADP-ribose) Polymerase Inhibitors Phase 2
9
Dimenhydrinate Approved 523-87-5 441281
10
Colistin Approved 1066-17-7, 1264-72-8 5311054
11
Nalidixic Acid Approved, Investigational 389-08-2 4421
12
Chitosan Experimental 9012-76-4 71853
13
3,3'-diindolylmethane Investigational Early Phase 1 1968-05-4
14
Trichostatin A Experimental Early Phase 1 58880-19-6
15
Indole-3-carbinol Investigational Early Phase 1 700-06-1 3712
16
Indole Experimental Early Phase 1 120-72-9 798
17 Vaccines
18 Anti-Infective Agents
19 Hemostatics
20 Anti-Bacterial Agents
21 Histamine Antagonists
22 Antimetabolites
23 Hypolipidemic Agents
24 Lipid Regulating Agents
25 Histamine H1 Antagonists
26 Coagulants
27 Anticholesteremic Agents
28 Chelating Agents
29 Emollients

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Phase II Study of Olaparib in Metastatic Renal Cell Carcinoma Patients Harboring a BAP-1 or Other DNA Repair Gene Mutations (ORCHID) Recruiting NCT03786796 Phase 2 Olaparib
2 Chiropractors Can Do: Testing the Feasibility of Intervening to Optimize Chiropractic Care for Adults With Neck Pain Disorders: A Pilot Cluster Randomized Controlled Trial Completed NCT02483091 Phase 1
3 Measurement and Comparison of the Occlusive and Hydrating Capacity of Three Silicone Gels: BAP Scar Gel, Dermatix, Kelocote and One Gel- Cream: Alhydran Completed NCT01413789 Dermatix;Kelocote;BAP scar gel;Alhydran;Bap Scar Care T;Bap Scar Care S;Mepiform;Scar Ban Elastic
4 The Use of Expanded Quantitative Urinary Culture (EQUC) Versus Standard Culture (SUC) Techniques in the Clinical Care of Women With Symptoms of Urinary Tract Infections. Completed NCT03190421
5 Pragmatic Randomized Controlled Multi Center Trial Comparing the Effectiveness of Antibacterial Therapeutic Clothing Based on Silver or Chitosan as Compared With Non-antibacterial Therapeutic Clothing in Patients With Moderate to Severe Atopic Dermatitis Recruiting NCT04297215
6 Human Embryonic Stem Cell-derived Trophoblastic Spheroid (BAP-EB) as a Predictive Tool for Endometrial Receptivity and Pregnancy Outcome of in Vitro Fertilization Treatment Recruiting NCT02713854
7 Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet Active, not recruiting NCT03802721 Early Phase 1 [14C]-benzo[a]pyrene;Brussels sprouts before 50 ng dose;DIM supplement before 50 ng dose

Search NIH Clinical Center for Bart-Pumphrey Syndrome

Sources

Genetic Tests for Bart-Pumphrey Syndrome

About this section

Genetic tests related to Bart-Pumphrey Syndrome:

# Genetic test Affiliating Genes
1 Knuckle Pads, Deafness and Leukonychia Syndrome 29 GJB2
Sources

Anatomical Context for Bart-Pumphrey Syndrome

About this section

MalaCards organs/tissues related to Bart-Pumphrey Syndrome:

40
Skin
Sources

Publications for Bart-Pumphrey Syndrome

About this section

Articles related to Bart-Pumphrey Syndrome:

(show all 16)
# Title Authors PMID Year
1
G59S mutation in the GJB2 (connexin 26) gene in a patient with Bart-Pumphrey syndrome. 61 6 57
15952212 2005
2
Expanding the phenotypic spectrum of Cx26 disorders: Bart-Pumphrey syndrome is caused by a novel missense mutation in GJB2. 6 57 61
15482471 2004
3
Familial leuconychia, knuckle pads, hearing loss, and palmoplantar hyperkeratosis: an additional family with Bart-Pumphrey syndrome. 57 61
8151643 1994
4
A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). 6
10633135 2000
5
Knuckle pads, leukonychia, deafness, and keratosis palmoplantaris: report of a family. 57
138007 1976
6
Knuckle pads, leukonychia and deafness. A dominantly inherited syndrome. 57
6015974 1967
7
[KERATOSIS PALMARIS ET PLANTARIS WITH CONGENITAL DEAFNESS AND TOTAL LEUKONYCHIA]. 57
14046203 1963
8
Bart-Pumphrey Syndrome. 61
32745176 2020
9
G59S mutation in the GJB2 gene in a Chinese family with classic Vohwinkel syndrome. 61
30565282 2019
10
Heimler's syndrome: a close mimic of Bart-Pumphrey syndrome. 61
26519192 2016
11
Overview of skin diseases linked to connexin gene mutations. 61
23675785 2014
12
Report of a family with idiopathic knuckle pads and review of idiopathic and disease-associated knuckle pads. 61
24011277 2013
13
The role of connexins in ear and skin physiology - functional insights from disease-associated mutations. 61
22796187 2013
14
A family of Bart-Pumphrey syndrome. 61
22421650 2012
15
A family with leukonychia totalis. 61
20418990 2010
16
Connexin-26 mutations in deafness and skin disease. 61
19939300 2009
Sources

Variations for Bart-Pumphrey Syndrome

About this section

ClinVar genetic disease variations for Bart-Pumphrey Syndrome:

6 (show all 26)
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 GJB2 NM_004004.6(GJB2):c.162C>A (p.Asn54Lys) SNV Pathogenic 17030 rs104894412 13:20763559-20763559 13:20189420-20189420
2 GJB2 NM_004004.6(GJB2):c.175G>A (p.Gly59Ser) SNV Pathogenic 17034 rs104894410 13:20763546-20763546 13:20189407-20189407
3 GJB2 NM_004004.6(GJB2):c.379C>T (p.Arg127Cys) SNV Pathogenic 163514 rs727503066 13:20763342-20763342 13:20189203-20189203
4 GJB2 NM_004004.6(GJB2):c.94C>A (p.Arg32Ser) SNV Pathogenic 550195 rs371024165 13:20763627-20763627 13:20189488-20189488
5 GJB2 NM_004004.6(GJB2):c.35del (p.Gly12fs) Deletion Pathogenic 17004 rs80338939 13:20763686-20763686 13:20189547-20189547
6 GJB2 NM_004004.6(GJB2):c.167del (p.Leu56fs) Deletion Pathogenic 17010 rs80338942 13:20763554-20763554 13:20189415-20189415
7 GJB2 NM_004004.6(GJB2):c.131G>A (p.Trp44Ter) SNV Pathogenic 188830 rs104894413 13:20763590-20763590 13:20189451-20189451
8 GJB2 NM_004004.6(GJB2):c.283G>A (p.Val95Met) SNV Pathogenic 44735 rs111033299 13:20763438-20763438 13:20189299-20189299
9 GJB2 NM_004004.6(GJB2):c.617A>G (p.Asn206Ser) SNV Pathogenic 44763 rs111033294 13:20763104-20763104 13:20188965-20188965
10 GJB2 NM_004004.6(GJB2):c.139G>T (p.Glu47Ter) SNV Pathogenic 17005 rs104894398 13:20763582-20763582 13:20189443-20189443
11 GJB2 NM_004004.6(GJB2):c.416G>A (p.Ser139Asn) SNV Pathogenic 44749 rs76434661 13:20763305-20763305 13:20189166-20189166
12 GJB2 NM_004004.6(GJB2):c.71G>A (p.Trp24Ter) SNV Pathogenic 17002 rs104894396 13:20763650-20763650 13:20189511-20189511
13 GJB2 NM_004004.6(GJB2):c.427C>T (p.Arg143Trp) SNV Pathogenic 17009 rs80338948 13:20763294-20763294 13:20189155-20189155
14 GJB2 NM_004004.6(GJB2):c.269T>C (p.Leu90Pro) SNV Pathogenic 17016 rs80338945 13:20763452-20763452 13:20189313-20189313
15 GJB2 NM_004004.6(GJB2):c.231G>A (p.Trp77Ter) SNV Pathogenic 17001 rs80338944 13:20763490-20763490 13:20189351-20189351
16 GJB2 NM_004004.6(GJB2):c.1A>G (p.Met1Val) SNV Pathogenic 44729 rs111033293 13:20763720-20763720 13:20189581-20189581
17 GJB2 NM_004004.6(GJB2):c.-23+1G>A SNV Pathogenic 17029 rs80338940 13:20766921-20766921 13:20192782-20192782
18 GJB2 NM_004004.6(GJB2):c.551G>C (p.Arg184Pro) SNV Pathogenic 17007 rs80338950 13:20763170-20763170 13:20189031-20189031
19 GJB2 NM_004004.6(GJB2):c.506G>A (p.Cys169Tyr) SNV Pathogenic 265481 rs774518779 13:20763215-20763215 13:20189076-20189076
20 GJB2 NM_004004.6(GJB2):c.427C>T (p.Arg143Trp) SNV Pathogenic 17009 rs80338948 13:20763294-20763294 13:20189155-20189155
21 GJB2 NM_004004.6(GJB2):c.101T>C (p.Met34Thr) SNV Pathogenic 17000 rs35887622 13:20763620-20763620 13:20189481-20189481
22 GJB2 NM_004004.6(GJB2):c.34G>T (p.Gly12Cys) SNV Likely pathogenic 44740 rs104894408 13:20763687-20763687 13:20189548-20189548
23 GJB2 NM_004004.6(GJB2):c.109G>A (p.Val37Ile) SNV Likely pathogenic 17023 rs72474224 13:20763612-20763612 13:20189473-20189473
24 GJB2 NM_004004.6(GJB2):c.188T>C (p.Val63Ala) SNV Uncertain significance 177751 rs727504309 13:20763533-20763533 13:20189394-20189394
25 GJB2 NM_004004.6(GJB2):c.670A>C (p.Lys224Gln) SNV Uncertain significance 44765 rs111033194 13:20763051-20763051 13:20188912-20188912
26 GJB2 NM_004004.6(GJB2):c.663G>C (p.Lys221Asn) SNV Uncertain significance 44764 rs375599392 13:20763058-20763058 13:20188919-20188919

UniProtKB/Swiss-Prot genetic disease variations for Bart-Pumphrey Syndrome:

73
# Symbol AA change Variation ID SNP ID
1 GJB2 p.Asn54Lys VAR_032750 rs104894412
2 GJB2 p.Gly59Ser VAR_032751 rs104894410

Sources

Expression for Bart-Pumphrey Syndrome

About this section
Search GEO for disease gene expression data for Bart-Pumphrey Syndrome.
Sources

Pathways for Bart-Pumphrey Syndrome

About this section

Pathways related to Bart-Pumphrey Syndrome according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Vesicle-mediated transport 65
Show member pathways
 12.96 GJC1 GJB6 GJB5 GJB4 GJB3 GJB2
2
G-Beta Gamma Signaling 63
Show member pathways
 12.63 GJC1 GJB6 GJB5 GJB4 GJB3 GJB2
3
Development Slit-Robo signaling 23
Show member pathways
 12.17 GJC1 GJB3 GJB2 GJB1 GJA1
4
Myometrial Relaxation and Contraction Pathways 1
Show member pathways
 12.05 GJC1 GJB6 GJB5 GJB4 GJB3 GJB2
5
Gap junction trafficking 65
Show member pathways
 11.22 GJC1 GJB6 GJB5 GJB4 GJB3 GJB2
6
Transport of connexins along the secretory pathway 65
Show member pathways
 10.45 GJB2 GJB1 GJA1
Sources

GO Terms for Bart-Pumphrey Syndrome

About this section

Cellular components related to Bart-Pumphrey Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 membrane GO:0016020 10.06 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3
2 integral component of membrane GO:0016021 9.97 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3
3 plasma membrane GO:0005886 9.91 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3
4 cell junction GO:0030054 9.81 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3
5 connexin complex GO:0005922 9.61 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3
6 lateral plasma membrane GO:0016328 9.43 GJB2 GJB1
7 intercalated disc GO:0014704 9.37 GJC1 GJA1
8 gap junction GO:0005921 9.28 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3

Biological processes related to Bart-Pumphrey Syndrome according to GeneCards Suite gene sharing:

(show all 15)
# Name GO ID Score Top Affiliating Genes
1 transmembrane transport GO:0055085 9.91 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3
2 response to lipopolysaccharide GO:0032496 9.65 GJB6 GJB2 GJA1
3 epididymis development GO:1905867 9.62 GJB5 GJB2 GJB1 GJA1
4 cell-cell signaling GO:0007267 9.61 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3
5 cell communication by electrical coupling GO:0010644 9.58 GJB6 GJB2 GJA1
6 response to ischemia GO:0002931 9.55 GJB2 GJA1
7 gap junction assembly GO:0016264 9.55 GJC1 GJB6 GJB2 GJB1 GJA1
8 inner ear development GO:0048839 9.54 GJB6 GJB2
9 gap junction-mediated intercellular transport GO:1990349 9.54 GJB6 GJB4 GJB2
10 response to retinoic acid GO:0032526 9.52 GJB2 GJA1
11 maintenance of permeability of blood-brain barrier GO:0035633 9.51 GJB6 GJA1
12 decidualization GO:0046697 9.49 GJB2 GJA1
13 atrial cardiac muscle cell action potential GO:0086014 9.46 GJC1 GJA1
14 AV node cell to bundle of His cell communication by electrical coupling GO:0086053 9.43 GJC3 GJC1
15 cell communication GO:0007154 9.28 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3

Molecular functions related to Bart-Pumphrey Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 gap junction channel activity GO:0005243 9.28 GJC3 GJC1 GJB6 GJB5 GJB4 GJB3
2 gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling GO:0086077 9.16 GJC3 GJC1
3 gap junction channel activity involved in cell communication by electrical coupling GO:1903763 9.13 GJB6 GJB2 GJA1
Sources

Sources for Bart-Pumphrey Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....